| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Organoids | 26 | 2026 | 305 | 6.480 |
Why?
|
| Rotavirus Infections | 20 | 2025 | 281 | 4.330 |
Why?
|
| Intestinal Mucosa | 21 | 2026 | 771 | 3.990 |
Why?
|
| Intestines | 16 | 2026 | 587 | 2.900 |
Why?
|
| Rotavirus | 18 | 2025 | 367 | 2.750 |
Why?
|
| Intestine, Small | 9 | 2024 | 291 | 1.570 |
Why?
|
| Host-Pathogen Interactions | 6 | 2026 | 254 | 1.210 |
Why?
|
| Stem Cells | 10 | 2023 | 702 | 1.180 |
Why?
|
| B-Lymphocytes | 6 | 2025 | 509 | 1.130 |
Why?
|
| Lymphocyte Activation | 3 | 2025 | 633 | 1.090 |
Why?
|
| Single-Cell Analysis | 3 | 2025 | 350 | 0.970 |
Why?
|
| Jejunum | 2 | 2025 | 123 | 0.920 |
Why?
|
| Gamma Rays | 1 | 2025 | 38 | 0.920 |
Why?
|
| Norovirus | 7 | 2026 | 287 | 0.900 |
Why?
|
| Photons | 1 | 2025 | 60 | 0.890 |
Why?
|
| Protons | 1 | 2025 | 94 | 0.890 |
Why?
|
| Intestinal Diseases | 3 | 2019 | 67 | 0.870 |
Why?
|
| Nasal Mucosa | 4 | 2026 | 88 | 0.860 |
Why?
|
| High-Throughput Screening Assays | 1 | 2025 | 119 | 0.860 |
Why?
|
| Gastrointestinal Diseases | 5 | 2021 | 343 | 0.850 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2025 | 93 | 0.840 |
Why?
|
| Caliciviridae Infections | 7 | 2026 | 286 | 0.800 |
Why?
|
| Intestinal Polyposis | 1 | 2023 | 17 | 0.800 |
Why?
|
| Virus Replication | 12 | 2026 | 608 | 0.800 |
Why?
|
| Antigens, Viral | 6 | 2011 | 395 | 0.750 |
Why?
|
| Dendritic Cells | 1 | 2025 | 439 | 0.720 |
Why?
|
| Adult Stem Cells | 2 | 2019 | 50 | 0.700 |
Why?
|
| Respiratory Syncytial Virus, Human | 4 | 2026 | 241 | 0.690 |
Why?
|
| Cell Differentiation | 5 | 2024 | 1928 | 0.690 |
Why?
|
| Immunoglobulin A | 3 | 2025 | 201 | 0.640 |
Why?
|
| Cell Culture Techniques | 6 | 2021 | 274 | 0.640 |
Why?
|
| Respiratory Syncytial Virus Infections | 4 | 2026 | 400 | 0.630 |
Why?
|
| Communicable Diseases | 1 | 2021 | 155 | 0.590 |
Why?
|
| Viral Tropism | 3 | 2026 | 55 | 0.570 |
Why?
|
| Microinjections | 1 | 2018 | 38 | 0.560 |
Why?
|
| Virion | 3 | 2008 | 115 | 0.530 |
Why?
|
| Microchip Analytical Procedures | 1 | 2017 | 4 | 0.520 |
Why?
|
| Colorectal Neoplasms | 1 | 2023 | 621 | 0.520 |
Why?
|
| Calcitriol | 5 | 2021 | 63 | 0.510 |
Why?
|
| Gastrointestinal Microbiome | 3 | 2026 | 842 | 0.510 |
Why?
|
| Microfluidics | 1 | 2017 | 31 | 0.500 |
Why?
|
| Regeneration | 1 | 2019 | 230 | 0.500 |
Why?
|
| Viremia | 3 | 2007 | 130 | 0.490 |
Why?
|
| Cytokines | 5 | 2025 | 1339 | 0.490 |
Why?
|
| Antibodies, Viral | 8 | 2013 | 1176 | 0.450 |
Why?
|
| Mice | 27 | 2026 | 18301 | 0.430 |
Why?
|
| Immunity, Innate | 7 | 2025 | 406 | 0.430 |
Why?
|
| Mice, Inbred C57BL | 10 | 2026 | 4738 | 0.420 |
Why?
|
| Animals | 34 | 2026 | 33912 | 0.410 |
Why?
|
| Models, Biological | 5 | 2020 | 1371 | 0.410 |
Why?
|
| Humans | 54 | 2026 | 131163 | 0.380 |
Why?
|
| IgA Deficiency | 1 | 2012 | 5 | 0.370 |
Why?
|
| Tissue Engineering | 3 | 2020 | 152 | 0.370 |
Why?
|
| Cells, Cultured | 5 | 2021 | 2885 | 0.340 |
Why?
|
| Transcriptome | 6 | 2025 | 1103 | 0.340 |
Why?
|
| Escherichia coli Infections | 3 | 2021 | 198 | 0.320 |
Why?
|
| Virus Cultivation | 3 | 2024 | 70 | 0.320 |
Why?
|
| Colon | 4 | 2026 | 373 | 0.310 |
Why?
|
| Organ Culture Techniques | 4 | 2018 | 140 | 0.300 |
Why?
|
| Space Flight | 2 | 2022 | 177 | 0.300 |
Why?
|
| Telomere | 2 | 2021 | 219 | 0.300 |
Why?
|
| Cell Proliferation | 5 | 2025 | 2465 | 0.300 |
Why?
|
| Prostatic Neoplasms | 5 | 2001 | 1419 | 0.290 |
Why?
|
| Bacterial Adhesion | 2 | 2020 | 104 | 0.290 |
Why?
|
| Rotavirus Vaccines | 2 | 2006 | 61 | 0.280 |
Why?
|
| Peyer's Patches | 2 | 2025 | 17 | 0.280 |
Why?
|
| Interferons | 2 | 2020 | 138 | 0.270 |
Why?
|
| Mice, Inbred BALB C | 6 | 2012 | 978 | 0.260 |
Why?
|
| Epithelial Cells | 5 | 2026 | 905 | 0.260 |
Why?
|
| Culture Media | 3 | 2024 | 171 | 0.260 |
Why?
|
| Capsid Proteins | 2 | 2005 | 146 | 0.250 |
Why?
|
| RNA, Viral | 2 | 2006 | 497 | 0.250 |
Why?
|
| Pentanoic Acids | 1 | 2026 | 9 | 0.240 |
Why?
|
| Enterocytes | 5 | 2024 | 68 | 0.240 |
Why?
|
| Gastroenteritis | 4 | 2024 | 308 | 0.220 |
Why?
|
| CD11c Antigen | 1 | 2025 | 40 | 0.220 |
Why?
|
| Diarrhea | 3 | 2021 | 301 | 0.220 |
Why?
|
| Disease Resistance | 1 | 2024 | 22 | 0.220 |
Why?
|
| Mucin-2 | 1 | 2024 | 39 | 0.220 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2024 | 71 | 0.210 |
Why?
|
| Nose | 1 | 2025 | 115 | 0.210 |
Why?
|
| Microscopy, Confocal | 1 | 2025 | 335 | 0.210 |
Why?
|
| Nutritional Status | 2 | 2012 | 298 | 0.210 |
Why?
|
| Phagocytosis | 1 | 2025 | 190 | 0.210 |
Why?
|
| Malnutrition | 1 | 2026 | 163 | 0.210 |
Why?
|
| Sequence Analysis, RNA | 3 | 2021 | 407 | 0.200 |
Why?
|
| Viruses | 2 | 2021 | 117 | 0.200 |
Why?
|
| Immunity | 1 | 2004 | 178 | 0.190 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2025 | 587 | 0.190 |
Why?
|
| Weightlessness | 1 | 2004 | 87 | 0.180 |
Why?
|
| Cosmic Radiation | 1 | 2022 | 14 | 0.180 |
Why?
|
| Serotonin | 1 | 2023 | 208 | 0.180 |
Why?
|
| Radiation Protection | 1 | 2022 | 51 | 0.180 |
Why?
|
| T-Lymphocytes | 3 | 2011 | 1722 | 0.180 |
Why?
|
| Gastrointestinal Tract | 2 | 2021 | 211 | 0.180 |
Why?
|
| Radiation Exposure | 1 | 2022 | 45 | 0.180 |
Why?
|
| Enterohepatic Circulation | 1 | 2021 | 10 | 0.170 |
Why?
|
| Liver | 2 | 2021 | 1796 | 0.170 |
Why?
|
| Enteropathogenic Escherichia coli | 1 | 2021 | 5 | 0.170 |
Why?
|
| Wnt Signaling Pathway | 1 | 2023 | 223 | 0.170 |
Why?
|
| Macrophages | 1 | 2025 | 667 | 0.170 |
Why?
|
| Gene Expression Profiling | 2 | 2025 | 1801 | 0.160 |
Why?
|
| Heparan Sulfate Proteoglycans | 1 | 2020 | 18 | 0.160 |
Why?
|
| Gluconeogenesis | 1 | 2020 | 93 | 0.160 |
Why?
|
| Hydrogels | 1 | 2021 | 92 | 0.160 |
Why?
|
| Microbiota | 1 | 2025 | 438 | 0.160 |
Why?
|
| Endometrium | 1 | 2023 | 292 | 0.150 |
Why?
|
| Probiotics | 2 | 2012 | 227 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2000 | 165 | 0.150 |
Why?
|
| Virus Diseases | 2 | 2021 | 285 | 0.150 |
Why?
|
| Escherichia coli | 3 | 2021 | 991 | 0.150 |
Why?
|
| Stomach | 1 | 2021 | 274 | 0.140 |
Why?
|
| Ileum | 1 | 2019 | 109 | 0.140 |
Why?
|
| Uterus | 1 | 2023 | 541 | 0.140 |
Why?
|
| Computers | 1 | 2018 | 66 | 0.140 |
Why?
|
| Virus Physiological Phenomena | 1 | 2018 | 12 | 0.140 |
Why?
|
| Tissue Culture Techniques | 2 | 2018 | 63 | 0.140 |
Why?
|
| Obesity, Morbid | 1 | 2020 | 232 | 0.130 |
Why?
|
| Escherichia coli Proteins | 1 | 2020 | 319 | 0.130 |
Why?
|
| Vitamin D | 1 | 1999 | 194 | 0.130 |
Why?
|
| Infant | 7 | 2026 | 13352 | 0.130 |
Why?
|
| Immunity, Mucosal | 2 | 2019 | 95 | 0.130 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2021 | 327 | 0.130 |
Why?
|
| G1 Phase | 1 | 1997 | 68 | 0.120 |
Why?
|
| Tretinoin | 1 | 1997 | 95 | 0.120 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2017 | 74 | 0.120 |
Why?
|
| Feces | 3 | 2021 | 721 | 0.120 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2020 | 619 | 0.120 |
Why?
|
| Apoptosis | 2 | 2000 | 1827 | 0.120 |
Why?
|
| Glucose | 1 | 2020 | 853 | 0.120 |
Why?
|
| Cell Cycle Proteins | 1 | 2020 | 710 | 0.120 |
Why?
|
| Blood-Brain Barrier | 1 | 2017 | 153 | 0.120 |
Why?
|
| Antigens, Differentiation | 1 | 2015 | 63 | 0.110 |
Why?
|
| Bacteria | 1 | 2019 | 521 | 0.110 |
Why?
|
| Species Specificity | 2 | 2006 | 470 | 0.110 |
Why?
|
| Signal Transduction | 2 | 2025 | 4686 | 0.110 |
Why?
|
| Mice, Knockout | 3 | 2024 | 3819 | 0.110 |
Why?
|
| Prostate | 1 | 1997 | 404 | 0.110 |
Why?
|
| Tumor Cells, Cultured | 4 | 2001 | 975 | 0.110 |
Why?
|
| Female | 13 | 2026 | 70963 | 0.100 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2015 | 289 | 0.100 |
Why?
|
| Antineoplastic Agents | 2 | 2001 | 1826 | 0.100 |
Why?
|
| Models, Theoretical | 1 | 2015 | 362 | 0.100 |
Why?
|
| Lymphotoxin-alpha | 1 | 2012 | 7 | 0.100 |
Why?
|
| Inflammation | 1 | 2020 | 1489 | 0.090 |
Why?
|
| Male | 14 | 2026 | 64957 | 0.090 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2000 | 2026 | 0.090 |
Why?
|
| Animals, Newborn | 2 | 2012 | 1021 | 0.090 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2013 | 236 | 0.090 |
Why?
|
| Adaptive Immunity | 1 | 2012 | 101 | 0.090 |
Why?
|
| Phenotype | 1 | 2020 | 4497 | 0.080 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 2 | 2021 | 94 | 0.080 |
Why?
|
| Interleukin-18 | 2 | 2021 | 75 | 0.080 |
Why?
|
| Muscle, Skeletal | 1 | 2017 | 981 | 0.080 |
Why?
|
| Viral Load | 1 | 2012 | 416 | 0.080 |
Why?
|
| Telomerase | 2 | 2021 | 154 | 0.080 |
Why?
|
| Body Weight | 2 | 2012 | 987 | 0.080 |
Why?
|
| Adhesins, Escherichia coli | 2 | 2020 | 17 | 0.080 |
Why?
|
| Gene Deletion | 1 | 2012 | 767 | 0.070 |
Why?
|
| Cell Division | 3 | 2001 | 718 | 0.070 |
Why?
|
| Calcium | 3 | 2007 | 1010 | 0.070 |
Why?
|
| Cell Movement | 1 | 2012 | 876 | 0.070 |
Why?
|
| Gene Expression | 1 | 2012 | 1481 | 0.070 |
Why?
|
| Cell Cycle | 2 | 2000 | 594 | 0.060 |
Why?
|
| HT29 Cells | 1 | 2007 | 44 | 0.060 |
Why?
|
| Diarrhea, Infantile | 1 | 2007 | 31 | 0.060 |
Why?
|
| Child | 5 | 2025 | 26341 | 0.060 |
Why?
|
| Actin Depolymerizing Factors | 1 | 2007 | 2 | 0.060 |
Why?
|
| Organ Specificity | 2 | 2018 | 394 | 0.060 |
Why?
|
| Toxins, Biological | 1 | 2007 | 38 | 0.060 |
Why?
|
| Immunoassay | 1 | 2007 | 126 | 0.060 |
Why?
|
| Bacterial Translocation | 1 | 2026 | 30 | 0.060 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2007 | 124 | 0.060 |
Why?
|
| Cell Line | 3 | 2019 | 2552 | 0.060 |
Why?
|
| Adult | 5 | 2025 | 31282 | 0.060 |
Why?
|
| Permeability | 1 | 2026 | 126 | 0.060 |
Why?
|
| Intussusception | 1 | 2006 | 54 | 0.060 |
Why?
|
| Neoplasms | 1 | 2021 | 3016 | 0.060 |
Why?
|
| Viral Nonstructural Proteins | 1 | 2007 | 139 | 0.060 |
Why?
|
| Chemokines | 1 | 2026 | 126 | 0.060 |
Why?
|
| Administration, Intranasal | 1 | 2005 | 130 | 0.060 |
Why?
|
| Paneth Cells | 1 | 2024 | 22 | 0.050 |
Why?
|
| Lipopolysaccharides | 1 | 2006 | 299 | 0.050 |
Why?
|
| Coculture Techniques | 1 | 2025 | 230 | 0.050 |
Why?
|
| Glycoproteins | 1 | 2007 | 346 | 0.050 |
Why?
|
| Animals, Outbred Strains | 1 | 2004 | 10 | 0.050 |
Why?
|
| Actins | 1 | 2007 | 321 | 0.050 |
Why?
|
| Hindlimb Suspension | 1 | 2004 | 16 | 0.050 |
Why?
|
| Rodent Diseases | 1 | 2003 | 15 | 0.050 |
Why?
|
| Goblet Cells | 1 | 2024 | 105 | 0.050 |
Why?
|
| Cattle Diseases | 1 | 2003 | 20 | 0.050 |
Why?
|
| Kinetics | 1 | 2025 | 1088 | 0.050 |
Why?
|
| Antigens, CD | 2 | 2002 | 410 | 0.050 |
Why?
|
| Antibody Formation | 1 | 2004 | 227 | 0.050 |
Why?
|
| Administration, Oral | 1 | 2005 | 711 | 0.050 |
Why?
|
| Discs Large Homolog 1 Protein | 1 | 2023 | 9 | 0.050 |
Why?
|
| Disease Susceptibility | 1 | 2024 | 274 | 0.050 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2023 | 32 | 0.050 |
Why?
|
| Streptococcus pneumoniae | 1 | 2025 | 389 | 0.050 |
Why?
|
| Rabbits | 1 | 2003 | 575 | 0.050 |
Why?
|
| Stem Cell Niche | 1 | 2023 | 55 | 0.050 |
Why?
|
| Moon | 1 | 2022 | 13 | 0.050 |
Why?
|
| GTPase-Activating Proteins | 1 | 2023 | 83 | 0.050 |
Why?
|
| Cattle | 1 | 2003 | 501 | 0.050 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 2002 | 33 | 0.050 |
Why?
|
| Immunologic Memory | 1 | 2004 | 195 | 0.050 |
Why?
|
| Lymphoid Tissue | 1 | 2002 | 47 | 0.050 |
Why?
|
| Lectins, C-Type | 1 | 2002 | 71 | 0.040 |
Why?
|
| Mice, Nude | 2 | 2001 | 700 | 0.040 |
Why?
|
| Epithelium | 1 | 2023 | 335 | 0.040 |
Why?
|
| Staphylococcus aureus | 1 | 2025 | 483 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2019 | 639 | 0.040 |
Why?
|
| Hyperplasia | 1 | 2002 | 191 | 0.040 |
Why?
|
| Rats | 3 | 2003 | 3370 | 0.040 |
Why?
|
| Ketones | 1 | 2001 | 25 | 0.040 |
Why?
|
| Integrins | 1 | 2002 | 89 | 0.040 |
Why?
|
| Phosphorylation | 2 | 2020 | 1571 | 0.040 |
Why?
|
| Immunoglobulin M | 1 | 2002 | 210 | 0.040 |
Why?
|
| Sex Factors | 1 | 2005 | 1356 | 0.040 |
Why?
|
| Proteoglycans | 1 | 2021 | 77 | 0.040 |
Why?
|
| Laminin | 1 | 2021 | 66 | 0.040 |
Why?
|
| Receptors, Calcitriol | 1 | 2001 | 60 | 0.040 |
Why?
|
| Biphenyl Compounds | 1 | 2001 | 75 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 1205 | 0.040 |
Why?
|
| Glucose Transporter Type 5 | 1 | 2020 | 4 | 0.040 |
Why?
|
| Glucose Transporter Type 2 | 1 | 2020 | 6 | 0.040 |
Why?
|
| Sodium-Glucose Transporter 1 | 1 | 2020 | 11 | 0.040 |
Why?
|
| Palivizumab | 1 | 2021 | 49 | 0.040 |
Why?
|
| Fimbriae, Bacterial | 1 | 2020 | 39 | 0.040 |
Why?
|
| Drug Combinations | 1 | 2021 | 270 | 0.040 |
Why?
|
| Caspase 1 | 1 | 2020 | 50 | 0.040 |
Why?
|
| Extracellular Matrix | 1 | 2021 | 232 | 0.040 |
Why?
|
| Collagen | 1 | 2021 | 273 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2012 | 4697 | 0.040 |
Why?
|
| Estrogens | 1 | 2023 | 434 | 0.040 |
Why?
|
| Biocompatible Materials | 1 | 2021 | 108 | 0.040 |
Why?
|
| Intestinal Absorption | 1 | 2020 | 170 | 0.040 |
Why?
|
| Fluorescent Antibody Technique, Direct | 1 | 2000 | 12 | 0.040 |
Why?
|
| Dietary Carbohydrates | 1 | 2020 | 106 | 0.040 |
Why?
|
| DNA Fragmentation | 1 | 2000 | 53 | 0.040 |
Why?
|
| Mice, Mutant Strains | 1 | 2020 | 356 | 0.040 |
Why?
|
| Protein Precursors | 1 | 2020 | 140 | 0.040 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2000 | 119 | 0.040 |
Why?
|
| Ki-67 Antigen | 1 | 2000 | 99 | 0.040 |
Why?
|
| Child, Preschool | 2 | 2025 | 15110 | 0.040 |
Why?
|
| Enteroendocrine Cells | 1 | 2019 | 18 | 0.040 |
Why?
|
| Polyethylene Glycols | 1 | 2021 | 235 | 0.040 |
Why?
|
| Hypercalcemia | 1 | 1999 | 41 | 0.040 |
Why?
|
| RANK Ligand | 1 | 2019 | 51 | 0.040 |
Why?
|
| Virulence Factors | 1 | 2020 | 180 | 0.040 |
Why?
|
| Immunocompromised Host | 1 | 2021 | 315 | 0.040 |
Why?
|
| Age Factors | 1 | 2025 | 2825 | 0.040 |
Why?
|
| Bariatric Surgery | 1 | 2020 | 154 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2002 | 502 | 0.030 |
Why?
|
| Crohn Disease | 1 | 2021 | 292 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2000 | 645 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2000 | 1013 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2000 | 765 | 0.030 |
Why?
|
| CRISPR-Cas Systems | 1 | 2020 | 317 | 0.030 |
Why?
|
| Retinoid X Receptors | 1 | 1997 | 25 | 0.030 |
Why?
|
| Terfenadine | 1 | 2017 | 2 | 0.030 |
Why?
|
| Receptors, Retinoic Acid | 1 | 1997 | 77 | 0.030 |
Why?
|
| Cholecalciferol | 1 | 2017 | 20 | 0.030 |
Why?
|
| Methylamines | 1 | 2017 | 20 | 0.030 |
Why?
|
| Drug Synergism | 1 | 1997 | 237 | 0.030 |
Why?
|
| Bile | 1 | 2016 | 44 | 0.030 |
Why?
|
| Ligands | 1 | 2018 | 481 | 0.030 |
Why?
|
| Biological Transport | 1 | 2017 | 329 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 2000 | 680 | 0.030 |
Why?
|
| Metabolome | 1 | 2017 | 326 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2014 | 149 | 0.030 |
Why?
|
| Lymphocyte Count | 1 | 2013 | 118 | 0.020 |
Why?
|
| Growth Hormone-Releasing Hormone | 1 | 1993 | 12 | 0.020 |
Why?
|
| Lymphocyte Depletion | 1 | 2013 | 124 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2021 | 2323 | 0.020 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2015 | 238 | 0.020 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 1993 | 69 | 0.020 |
Why?
|
| Lung | 1 | 2021 | 1535 | 0.020 |
Why?
|
| Virus Shedding | 1 | 2012 | 76 | 0.020 |
Why?
|
| Plasma Cells | 1 | 2012 | 55 | 0.020 |
Why?
|
| Leukocytes | 1 | 2013 | 205 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2012 | 263 | 0.020 |
Why?
|
| Thinness | 1 | 2012 | 71 | 0.020 |
Why?
|
| Hypothalamus | 1 | 1993 | 206 | 0.020 |
Why?
|
| Metagenome | 1 | 2012 | 138 | 0.020 |
Why?
|
| Base Sequence | 2 | 2012 | 2730 | 0.020 |
Why?
|
| Antibodies | 1 | 2012 | 322 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2012 | 226 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2013 | 371 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2024 | 8635 | 0.020 |
Why?
|
| DNA Primers | 1 | 2012 | 599 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 1997 | 1211 | 0.020 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2012 | 377 | 0.020 |
Why?
|
| Phylogeny | 1 | 2012 | 689 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2020 | 1459 | 0.020 |
Why?
|
| Pregnancy | 1 | 2023 | 7512 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2011 | 585 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 1993 | 1447 | 0.020 |
Why?
|
| Overweight | 1 | 2012 | 387 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 1997 | 1939 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 2596 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 1591 | 0.020 |
Why?
|
| Transcription Factors | 1 | 1997 | 2406 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 1993 | 2550 | 0.020 |
Why?
|
| Gastrointestinal Transit | 1 | 2006 | 32 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2007 | 341 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2003 | 17753 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2006 | 787 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 2006 | 544 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 1618 | 0.010 |
Why?
|
| Time Factors | 1 | 2012 | 6196 | 0.010 |
Why?
|
| Receptors, Collagen | 1 | 2002 | 6 | 0.010 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 2002 | 17 | 0.010 |
Why?
|
| Sialic Acids | 1 | 2002 | 17 | 0.010 |
Why?
|
| Integrin alpha2 | 1 | 2002 | 9 | 0.010 |
Why?
|
| Integrin alpha4beta1 | 1 | 2002 | 26 | 0.010 |
Why?
|
| Integrin beta1 | 1 | 2002 | 51 | 0.010 |
Why?
|
| CHO Cells | 1 | 2002 | 152 | 0.010 |
Why?
|
| Growth Inhibitors | 1 | 2001 | 35 | 0.010 |
Why?
|
| Neuraminidase | 1 | 2002 | 40 | 0.010 |
Why?
|
| Cricetinae | 1 | 2002 | 362 | 0.010 |
Why?
|
| Random Allocation | 1 | 2001 | 409 | 0.010 |
Why?
|
| Transfection | 1 | 2002 | 962 | 0.010 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2001 | 1011 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2002 | 981 | 0.010 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 1993 | 38 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1993 | 1105 | 0.000 |
Why?
|
| Molecular Sequence Data | 1 | 1993 | 3464 | 0.000 |
Why?
|